Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Works of Christopher E. Jensen being referenced
A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma
2018
KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Christopher E. Jensen | 38 | 103 | 12 | 68 | 50 | 31 | 287 | |
| Basma Merhi | 40 | 60 | 8 | 59 | 41 | 26 | 297 | |
| Michelle Brown | 24 | 73 | 8 | 42 | 52 | 21 | 319 | |
| Mira Hellmann | 29 | 63 | 11 | 54 | 35 | 23 | 285 | |
| Richa Chauhan | 46 | 52 | 54 | 37 | 47 | 43 | 263 | |
| Jiraporn Srinakarin | 12 | 108 | 18 | 28 | 31 | 27 | 310 | |
| Kazuya Kabei | 36 | 32 | 9 | 62 | 37 | 37 | 316 | |
| David Hughes | 45 | 96 | 22 | 56 | 46 | 26 | 317 | |
| Amie E. Hwang | 10 | 106 | 7 | 77 | 46 | 29 | 315 | |
| Surupa Basu | 19 | 40 | 9 | 29 | 44 | 43 | 313 | |
| Zarina Abdul Latiff | 68 | 66 | 81 | 40 | 44 | 42 | 301 |
All Works
Login with ORCID to disown or claim papers
Loading papers...